DiagnosTear Technologies, Inc. (DTR) Price & Analysis

0 Followers

DTR Stock Chart & Stats

C$0.27

C$0.00(0.00%)

At close: Jan 07 4:00 PM EST

C$0.27

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.25 - C$0.88

Previous CloseN/A

Volume500.00

Average Volume (3M)47.94K

Market Cap

C$18.19M

Enterprise ValueC$23.93M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.38

Next Earnings

Sep 02, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding60,638,336

10 Day Avg. Volume112,571

30 Day Avg. Volume47,944

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DiagnosTear Technologies, Inc. News

DiagnosTear Wins French Approvals to Launch TeaRx Red Eye Clinical Study with AlyaTec

An announcement from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) is now available. DiagnosTear Technologies has secured all necessary...

5M ago

DiagnosTear Partners with Hanson Medical to Advance TeaRx Dry-Eye Test in U.K. Market

DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) just unveiled an update. DiagnosTear Technologies has signed a Letter of Intent...

5M ago

DiagnosTear Targets Indian Ophthalmic Market With TeaRx Distribution LOI

The latest announcement is out from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ). DiagnosTear Technologies has signed a Letter...

6M ago

DiagnosTear Reports Strong Interim Data for TeaRx Red Eye Diagnostic Platform

An announcement from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) is now available. DiagnosTear Technologies reported highly encouraging interim...

7M ago

DiagnosTear Technologies Confirms No Material Change Amid Market Activity

DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) has shared an update. DiagnosTear Technologies Inc. announced that there is no...

8M ago

DiagnosTear Partners with AlyaTec for TeaRx™ Red Eye Clinical Study

DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) has provided an announcement. DiagnosTear Technologies Inc. has announced a collaboration with...

8M ago

DiagnosTear Partners with LV Prasad Eye Institute for Red Eye Diagnostic Advancement

An update from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) is now available. DiagnosTear Technologies Inc. has announced a...

8M ago

DiagnosTear Technologies Secures $925,000 in Private Placement

DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) has shared an update. DiagnosTear Technologies Inc. announced the successful closing of...

9M ago

DiagnosTear Technologies Upsizes Private Placement to $1 Million

An update from DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) is now available. DiagnosTear Technologies Inc. announced an increase...

9M ago

DiagnosTear Technologies Announces $700,000 Private Placement to Enhance Financial Position

DiagnosTear Technologies, Inc. ( ($TSE:DTR) ) has shared an announcement. DiagnosTear Technologies Inc. has announced a non-brokered private...

1y ago

DTR FAQ

What was DiagnosTear Technologies, Inc.’s price range in the past 12 months?

DiagnosTear Technologies, Inc. lowest stock price was C$0.25 and its highest was C$0.88 in the past 12 months.

What is DiagnosTear Technologies, Inc.’s market cap?

DiagnosTear Technologies, Inc.’s market cap is C$18.19M.

When is DiagnosTear Technologies, Inc.’s upcoming earnings report date?

DiagnosTear Technologies, Inc.’s upcoming earnings report date is Sep 02, 2026 which is in 30 days.

How were DiagnosTear Technologies, Inc.’s earnings last quarter?

Currently, no data Available

Is DiagnosTear Technologies, Inc. overvalued?

According to Wall Street analysts DiagnosTear Technologies, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does DiagnosTear Technologies, Inc. pay dividends?

DiagnosTear Technologies, Inc. does not currently pay dividends.

What is DiagnosTear Technologies, Inc.’s EPS estimate?

DiagnosTear Technologies, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does DiagnosTear Technologies, Inc. have?

DiagnosTear Technologies, Inc. has 60,638,336 shares outstanding.

What happened to DiagnosTear Technologies, Inc.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of DiagnosTear Technologies, Inc.?

Currently, no hedge funds are holding shares in TSE:DTR

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

DiagnosTear Technologies, Inc.

DiagnosTear is focused on the diagnosis of front-of-the-eye diseases at the point of care, by analyzing the composition of the tear fluid using its proprietary non invasive TeaRx¿ technology and currently has two products for diagnosis of Dry Eye Disease and Red Eye causes.